The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

Food makers and restaurants adjust menus and products as GLP-1 drugs drive demand for high-protein foods and smaller portions ...

The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss pill on Monday, giving the Danish drugmaker a leg ...

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer’s, according to two large new studies. The ...

Weight-loss drug semaglutide, also used to treat type-2 diabetes, will face its next big turning point in early 2026, when patents held by Novo Nordisk expire in India. The Danish company sells the ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. What Happens If You Use Expired Semaglutide? Wondering what happens if you use expired semaglutide? For one, it can make the ...

Real world data show tirzepatide and semaglutide reduce heart attack, stroke and death in type 2 diabetes Benefits appear early and are stronger than for older comparator drugs Head to head analyses ...

The Delhi High Court allowed Dr. Reddy’s to manufacture semaglutide in India and export it internationally but barred domestic sales until March 2026, when Novo Nordisk’s secondary patent expires.

A new generation of weight-loss ‘super-jabs’ could help those who struggle to ditch the pounds with existing drugs, such as semaglutide and tirzepatide. The new treatments are designed to give a ...

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well ...

The U.S. has revealed price reductions for the second round of prescription drugs negotiated by the Centers for Medicare & Medicaid Services (CMS) through the Inflation Reduction Act (IRA). Headlining ...